-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Lipella Pharmaceuticals Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2022 to Q1 2024.
- Lipella Pharmaceuticals Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$1.39M, a 28.8% decline year-over-year.
- Lipella Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$3.15M, a 72% decline from 2022.
- Lipella Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$1.83M, a 85.1% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)